Melanoma Clinical Trials

Showing 401-420 of 705 trials

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

NCT02897765

The purpose of this study is to evaluate if the treatment with NEO-PV-01 + adjuvant in combination with nivolumab is safe and useful for patients with certain types of cancer. The study also will investigate if NEO-PV-01 + adjuvant with nivolumab may represent a substantial improvement over other available therapies such as nivolumab alone. All eligible patients will receive NEO-PV-01 + adjuvant and nivolumab while on this trial.

Urinary Bladder CancerBladder TumorsTransitional Cell Carcinoma of the Bladder+5 more

BioNTech US Inc.34 participantsStarted Oct 2016

Duarte, California, United States • Los Angeles, California, United States • San Francisco, California, United States +6 more locations

UNKNOWNPHASE2

Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma

NCT02617849

This is a multi-center, open-label, Phase II clinical trial evaluating pembrolizumab in combination with carboplatin/paclitaxel as a treatment in unresectable locally advanced or metastatic melanoma.

Metastatic Malignant Melanoma

Wilson Miller30 participantsStarted May 2016

Montreal, Quebec, Canada • Montreal, Quebec, Canada

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma

Related Searches

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Encorafenib + Binimetinib + Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma

A Study of HX008 for the Treatment of Patients With Malignant Melanoma

Location of Lower Limb Cutaneous Melanomas as a Prognostic Factor.

Clinical Study to Evaluate OrienX010 in Combination With Toripalimab as Neoadjuvant Treatment in Advanced Melanoma

Neoadjuvant Vemurafenib + Cobimetinib + Atezolizumab in Melanoma: NEO-VC

Vaccination Plus Ontak in Patients With Metastatic Melanoma

Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma

Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment

Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma

Trial of pIL-12/MK-3475 in Metastatic Melanoma

Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm

Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma

In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®

A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors

Passive Versus Active Educational Interventions for Melanoma Recognition

Suction Drain in Axillary Lymph Node Dissection for Malignant Melanoma

Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer